Difference between revisions of "Talk:Papillary renal cell carcinoma"

From Libre Pathology
Jump to navigation Jump to search
 
 
(3 intermediate revisions by the same user not shown)
Line 6: Line 6:
Oncocytic PaRCC Type vs Type 2 - 2013 - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693205/
Oncocytic PaRCC Type vs Type 2 - 2013 - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693205/
*probably a separate category; doesn't fit into type 1 vs type 2
*probably a separate category; doesn't fit into type 1 vs type 2
== ABCC2 ==
https://pubmed.ncbi.nlm.nih.gov/37680023/
https://www.sigmaaldrich.com/CA/en/product/sigma/hpa004860
<pre>
ABCC2 brush border staining in the tumour is PRESENT, patchy and estimated as 50%; the presence of significant ABCC2 staining suggests a more aggressive disease.[1]
1. Histopathology. 2023 Dec;83(6):949-958. doi: 10.1111/his.15042.
</pre>
<pre>
Significant ABCC2 brush border staining in the tumour is ABSENT (<50%).
</pre>

Latest revision as of 16:34, 3 July 2025

Oncocytic papillary renal cell carcinoma

Oncocytic PaRCC, Type 1 vs Type 2 - 2017: https://pubmed.ncbi.nlm.nih.gov/27931799/

  • has features of both

Oncocytic PaRCC Type vs Type 2 - 2013 - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693205/

  • probably a separate category; doesn't fit into type 1 vs type 2

ABCC2

https://pubmed.ncbi.nlm.nih.gov/37680023/

https://www.sigmaaldrich.com/CA/en/product/sigma/hpa004860

ABCC2 brush border staining in the tumour is PRESENT, patchy and estimated as 50%; the presence of significant ABCC2 staining suggests a more aggressive disease.[1]

1. Histopathology. 2023 Dec;83(6):949-958. doi: 10.1111/his.15042.


Significant ABCC2 brush border staining in the tumour is ABSENT (<50%).